We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TENX market cap is 19.2M. The company's latest EPS is USD -2.2620 and P/E is -2.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.12M | -3.34M | -3.91M | -3.67M | -4.62M |
| Net Income | -1.97M | -3.23M | -3.8M | -3.58M | -3.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.56M | -9.87M | -32.73M | -11.05M | -8.23M |
| Net Income | -8.39M | -9.85M | -32.47M | -11.05M | -7.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.89M | 11.69M | 14.46M | 10.62M | 99.79M |
| Total Liabilities | 602k | 3.59M | 2.03M | 1.74M | 2.56M |
| Total Equity | 11.29M | 8.1M | 12.43M | 8.88M | 97.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.37M | 50M | 5.99M | 3.41M | 11.69M |
| Total Liabilities | 2.59M | 0 | 1.75M | 1.91M | 3.59M |
| Total Equity | 3.77M | 50M | 4.25M | 1.49M | 8.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.73M | -5.9M | -5.17M | -8.2M | -11.28M |
| Investing | 3k | 3k | N/A | N/A | N/A |
| Financing | 13.74M | 13.57M | 7.92M | 7.79M | 99.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.56M | -9.27M | -10.86M | -12.01M | -5.9M |
| Investing | -2k | 20k | 452k | -2k | 3k |
| Financing | 97k | 10.6M | 9.74M | 8.56M | 13.57M |
| Market Cap | 19.2M |
| Price to Earnings Ratio | -2.49 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.96 |
| Price to Book Ratio | 2.37 |
| Dividend Yield | - |
| Shares Outstanding | 3.41M |
| Average Volume (1 week) | 24.35k |
| Average Volume (1 Month) | 66.8k |
| 52 Week Change | -77.26% |
| 52 Week High | 27.3272 |
| 52 Week Low | 2.77 |
| Spread (Intraday) | 0.1 (1.77%) |
| Company Name | Tenax Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.tenaxthera.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
